(1)
CLINICAL UTILITY OF CIRCULATING TUMOR DNA (ctDNA) AS A PROGNOSTIC MARKER IN NON-SMALL CELL LUNG CANCER: A PROSPECTIVE COHORT STUDY. FMHR 2025, 3 (6), 1724-1731.